Deal score
Domain rating
Backlinks
Organic traffic
Current bid
Auction ends
DR-25 authority for $710 · 532 referring domains · real content since 2013
Auction ended
$1,305
below valuation
18
competing bids
Auction ended
remaining
Ahrefs organic traffic
Wayback captures by year
Backlink quality
Recorded backlink quality is 50/100.
Marketplace content flag
GoDaddy content classification is not available.
Archive continuity
Largest recorded archive gap is 345 days.
Actual links pointing to this domain
| Source page | DR | Anchor and target | Type | Status | |
|---|---|---|---|---|---|
pr FIZE Medical Completes $5.3 Million Series A Financing prnewswire.com | 92 | and interim CEO of portfolio company AsclepiX Therapeutics, Inc. ( www.asclepix.com ) in 2020, engineering their $35 million Series A financing led byasclepix.com | Raw HTML | Indexed | |
en Eric Bressler '14 - Department of Materials Science & Engineering engineering.jhu.edu | 91 | Since graduating, Bressler has worked as a Research Specialist at AsclepiX Therapeutics . The company was founded by Dr. Jordan Green andasclepix.com | Raw HTML | Indexed | |
cr AsclepiX Therapeutics - Crunchbase Company Profile & Funding crunchbase.com | 91 | asclepix.com/asclepix.com | Rendered | Indexed | |
fo Term Sheet -- Monday, November 5 | Fortune fortune.com | 91 | AsclepiX Therapeutics , Incasclepix.com | Rendered | Indexed | |
ey Tyrosine Kinase Inhibitors - EyeWiki eyewiki.org | 75 | DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD). AsclepiX Therapeutics. https://asclepix.com/asclepix-therapeutics-completes-enrollment-in-discover-trial-for-neovascular-age-related-macular-degeneration-namd/asclepix.com/asclepix-therapeutics-completes-enrollment-in-discover-trial-for-neovascular-age-related-macular-degeneration-namd/ | Raw HTML | Indexed |
Websites currently linking to this domain
Showing a stored sample of 3 of 532 referring domains reported by Ahrefs.
Referring Domain | ||
|---|---|---|
| businessinsider.com | 86 | 1 |
| substack.com | 86 | 2 |
| springer.com | 79 | 1 |
3 entries
Strong traffic, highly concentrated
Ahrefs organic traffic
Keyword | ||
|---|---|---|
| asclepix therapeutics | 3 | 60 |
Archive workspace
Archive verdict
Real content on both sides of the largest gap — consistent with a drop-catch or repurpose. Verify with the linked captures before relying on it.
First real content
first 200 HTML calc
Last real content
not the last capture
Coverage
of 160 span months
Largest gap
Monthly · UTC · zero months shown
Era classification is inf from the capture mix.
Peak cadence
20,094/mo calc
Content months
116 calc
Material gaps
2 calc
Largest gap · 345 dayscalc
Cadence 0/mo before → 26/mo after. calc
No captures since calc
Aug 2026 — 14 days and counting.
Not counted as a gap: nothing bounds it on the far side. Absence of captures is not proof the site is down.
Other material gaps
Explore historical captures of the domain
URL | Type | View | |||||
|---|---|---|---|---|---|---|---|
| /asclepix.com | 05/13/202511:37 UTC | 200 | HTML document | 28.7 KB | 331 | 168 | View |
| /technology/asclepix.com | 07/16/202405:32 UTC | 200 | HTML document | 17.3 KB | 97 | 46 | View |
| /company-overview/asclepix.com | 10/15/201807:04 UTC | 200 | HTML document | 14.2 KB | 68 | 18 | View |
| /news/www.asclepix.com | 02/18/202000:37 UTC | 200 | HTML document | 11.0 KB | 67 | 21 | View |
| /about-us/asclepix.com | 10/13/201810:53 UTC | 200 | HTML document | 14.2 KB | 61 | 19 | View |
| /about/asclepix.com | 08/15/202419:59 UTC | 200 | HTML document | 22.5 KB | 58 | 38 | View |
| /asclepix-advantages/asclepix.com | 10/15/201807:53 UTC | 200 | HTML document | 14.1 KB | 54 | 15 | View |
| /anti-angiogenesis-therapy/asclepix.com | 10/13/201810:47 UTC | 200 | HTML document | 14.0 KB | 54 | 15 | View |
| /immunology/asclepix.com | 10/13/201809:52 UTC | 200 | HTML document | 13.7 KB | 52 | 14 | View |
| /contact-us/asclepix.com | 10/15/201807:16 UTC | 200 | HTML document | 14.5 KB | 52 | 14 | View |
| /patents-publications/asclepix.com | 10/17/201816:29 UTC | 200 | HTML document | 21.3 KB | 52 | 13 | View |
| /contact/asclepix.com | 08/14/202423:08 UTC | 200 | HTML document | 16.7 KB | 50 | 33 | View |
| /ophthalmology/asclepix.com | 10/17/201818:06 UTC | 200 | HTML document | 14.2 KB | 48 | 15 | View |
| /creating-cures/asclepix.com | 10/13/201810:28 UTC | 200 | HTML document | 14.9 KB | 47 | 15 | View |
| /terms-of-use/asclepix.com | 06/13/202409:52 UTC | 200 | HTML document | 23.5 KB | 45 | 29 | View |
| /privacy-policy/asclepix.com | 04/19/202403:21 UTC | 200 | HTML document | 22.0 KB | 42 | 26 | View |
| /pipeline/asclepix.com | 06/13/202410:43 UTC | 200 | HTML document | 23.4 KB | 40 | 36 | View |
| /management-team/asclepix.com | 10/13/201809:35 UTC | 200 | HTML document | 16.6 KB | 34 | 13 | View |
| /media-center/asclepix.com | 06/13/202409:40 UTC | 200 | HTML document | 26.4 KB | 29 | 24 | View |
| /careers/asclepix.com | 06/13/202409:32 UTC | 200 | HTML document | 29.5 KB | 25 | 17 | View |
Showing 1–20 of 50 captures